Research only
Research Library
Source-cited reviews across the public catalog. Study models, molecular identity, conflicting findings, and evidence limits are labeled explicitly.
Peptide identity & analytical references
- Semaglutide identity and analytical reference
- Retatrutide identity and analytical reference
- Tirzepatide identity and analytical reference — Tirzepatide reference information limited to nomenclature, literature identifier LY3298176, CAS identity, and lot-specific analytical documentation.
Mitochondrial & cellular aging
- MOTS-c research overview
- Epithalon research overview — What selected cell-culture studies report about Epithalon, telomerase, and telomere-associated measurements—and what they cannot show.
- FOXO4-DRI research overview — A source-cited summary of FOXO4-DRI, the FOXO4–p53 interaction hypothesis, and the preclinical status of the evidence.
- SS-31 (elamipretide) research overview — A source-cited guide to the mitochondria-targeted tetrapeptide SS-31, cardiolipin interactions, and selected human mechanistic research.
Metabolic & energy research
- 5-Amino-1MQ research overview — What primary cell, mouse, and rat studies show about 5-Amino-1MQ as an experimental NNMT inhibitor.
- Vitamin B-12 research overview — A source-cited overview of cobalamin biochemistry, transport, and the limits of inferring outcomes from a research material.
- L-Carnitine research overview — A biochemical overview of L-carnitine, acylcarnitine transport, and mitochondrial fatty-acid transfer.
- NAD+ research overview — A source-cited overview of NAD+ as a redox cofactor, enzyme substrate, and compartmentalized cellular metabolite.
- SLU-PP-332 research overview — Primary preclinical evidence on SLU-PP-332 as an experimental estrogen-related-receptor agonist.
Tissue & cellular signaling
- BPC-157 research overview — A critical review of cell and animal research on BPC-157, including angiogenic and tendon models and major evidence gaps.
- GHK-Cu research overview — Primary animal and cell evidence on the glycyl-L-histidyl-L-lysine copper complex and extracellular-matrix measurements.
- KPV research overview — What cell and mouse studies show about the Lys-Pro-Val tripeptide derived from the C-terminus of alpha-MSH.
- Thymosin Beta-4 and LKKTETQ fragment research overview — A necessary distinction between full-length 43-residue Thymosin Beta-4 and the 17–23 LKKTETQ actin-binding fragment.
Neuro research
- Cerebrolysin research overview — A balanced look at Cerebrolysin as a complex peptide mixture, including selected randomized studies with positive and null findings.
- Selank research overview — A source-cited summary of Selank, a tuftsin-derived heptapeptide studied mainly in rodent stress and behavioral models.
- Semax research overview — What rat BDNF, ischemia, and transcriptomic studies can—and cannot—show about the ACTH(4–7)PGP analogue Semax.
Endocrine & receptor signaling
- CJC-1295 (no DAC) research overview — Why CJC-1295 with DAC and no-DAC GRF(1-29) materials must not be treated as the same research compound.
- Human chorionic gonadotropin (hCG) research overview — A molecular overview of hCG structure, LHCGR engagement, and why preparation-specific signaling matters.
- Ipamorelin research overview — A source-cited guide to ipamorelin's growth-hormone-secretagogue pharmacology in cells, animals, and a small human study.
- Melanotan II research overview — Selected receptor and early human research on the nonselective cyclic melanocortin agonist Melanotan II.
- Sermorelin research overview — A source-cited overview of GHRH(1-29)-amide, pituitary growth-hormone release, and study-design limits.
- Tesamorelin research overview — A source-cited overview of tesamorelin as a stabilized GHRH analogue and the narrow populations studied in randomized trials.
Formulations & research kits
- BPC-157 + TB-500 formulation research overview — Ingredient-level evidence and the crucial absence of direct evidence for the exact commercial blend.
- KLOW formulation research overview — Ingredient-level research for BPC-157, TB-500-related material, GHK-Cu, and KPV—without unsupported blend claims.
- Cellular Reserve research kit overview — A formulation-level boundary and links to ingredient evidence for Epithalon, BPC-157/TB-500, Tesamorelin, and Ipamorelin.
- SculptAxis research kit overview — Ingredient-level evidence for no-DAC GRF(1-29), Ipamorelin, Tesamorelin, and Tirzepatide, with no claims for the exact kit.
- DermaLuxe research kit overview — A clear separation of ingredient research from unsupported claims about the CJC no-DAC, Tesamorelin, Ipamorelin, and GHK-Cu kit.
- NeuroAxis research kit overview — Ingredient-level evidence for Cerebrolysin, BPC-157/TB-500-related material, and Selank, with explicit combination limits.
Research methods & comparisons
- Semaglutide vs tirzepatide vs retatrutide: a research comparison — An identity-first comparison of semaglutide, tirzepatide, and retatrutide using literature identifiers, CAS records, and batch-documentation boundaries.
- GLP catalog shorthand and literature identifiers explained — How GLP-1, GLP-2, and GLP-3 catalog shorthand maps to semaglutide, tirzepatide, and retatrutide without replacing full material identifiers.
- MOTS-c vs SS-31: two different mitochondrial research peptides — A source-cited comparison of a mitochondrial-genome-encoded signaling peptide and a synthetic cardiolipin-associated tetrapeptide.
- Semax vs Selank: sequence, model, and evidence differences — A cautious comparison of two short synthetic peptides whose evidence bases are dominated by different rodent and molecular studies.
- BPC-157 vs TB-500-related material: what the studies actually identify — Why BPC-157, full-length Thymosin Beta-4, the LKKTETQ fragment, and products labeled TB-500 must not be treated as one evidence base.
- How to read a peptide COA: HPLC, mass spectrometry, and identity — A practical analytical-literacy guide explaining why chromatographic purity, molecular mass, content, and batch traceability answer different questions.
- 5-Amino-1MQ and NNMT inhibition: mechanism and model limits — A source-cited guide to 5-Amino-1MQ, nicotinamide N-methyltransferase inhibition, and the boundaries between biochemical, mouse, and rat evidence.
- SLU-PP-332 and ERR signaling: what “exercise mimetic” means in research — A primary-source guide to SLU-PP-332, estrogen-related-receptor agonism, mouse exercise models, and why preclinical shorthand is not a human outcome.
- FOXO4-DRI, p53, and cellular senescence: an evidence guide — A source-cited explanation of the FOXO4–p53 interaction hypothesis, D-retro-inverso peptide design, and the limits of selected cell and mouse studies.
Repair & inflammatory models
- GHK-Cu, copper binding, and tissue-repair models: an evidence guide — A primary-source guide to the GHK copper complex, fibroblast collagen experiments, wound models, and why formulation details change the interpretation.
- KPV, PepT1, and NF-kappaB: what intestinal inflammation models show — A source-cited guide to the Lys-Pro-Val tripeptide, PepT1-mediated uptake, inflammatory signaling assays, and mouse colitis model limits.
- Epithalon, telomerase, and telomeres: separating cell findings from longevity claims — A primary-source guide to Epithalon cell experiments, telomerase and ALT measurements, mouse longevity observations, and the limits of anti-aging language.
- Cerebrolysin is a peptide mixture: composition, assays, and evidence limits — A source-cited guide to Cerebrolysin as a porcine-brain-derived peptide mixture, analytical characterization, bioassays, and why one trial cannot define the material.
Latest articles
- HPLC vs LC-MS for Peptide Testing: What Each Method Shows — Learn the difference between HPLC and LC-MS in peptide testing, including how HPLC evaluates purity and how LC-MS helps confirm molecular identity for research-use-only materials.
- How to Read a Peptide COA: HPLC, LC-MS, Purity, and Batch Testing Explained — Learn how to read a peptide Certificate of Analysis, including HPLC purity, LC-MS identity confirmation, batch numbers, chromatograms, and common COA red flags for research-use-only materials.
Research-use-only materials are not for human or animal use. Literature summaries do not substitute for batch-specific analytical documentation.